Primecap Management’s Calithera Biosciences, Inc CALA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-401,080
| Closed | -$1.31M | – | 342 |
|
2022
Q4 | $1.31M | Sell |
401,080
-13,400
| -3% | -$43.7K | ﹤0.01% | 308 |
|
2022
Q3 | $1.22M | Sell |
414,480
-5,800
| -1% | -$17.1K | ﹤0.01% | 311 |
|
2022
Q2 | $1.03M | Sell |
420,280
-116,370
| -22% | -$286K | ﹤0.01% | 319 |
|
2022
Q1 | $4.34M | Hold |
536,650
| – | – | ﹤0.01% | 290 |
|
2021
Q4 | $7.14M | Buy |
536,650
+6,215
| +1% | +$82.7K | ﹤0.01% | 284 |
|
2021
Q3 | $23.1M | Buy |
530,435
+13,250
| +3% | +$578K | 0.02% | 235 |
|
2021
Q2 | $21.6M | Buy |
517,185
+500
| +0.1% | +$20.9K | 0.01% | 239 |
|
2021
Q1 | $25M | Buy |
516,685
+4,010
| +0.8% | +$194K | 0.02% | 230 |
|
2020
Q4 | $50.3M | Buy |
512,675
+9,600
| +2% | +$943K | 0.04% | 189 |
|
2020
Q3 | $34.7M | Sell |
503,075
-315
| -0.1% | -$21.7K | 0.03% | 188 |
|
2020
Q2 | $53.2M | Buy |
503,390
+30,585
| +6% | +$3.23M | 0.05% | 169 |
|
2020
Q1 | $42M | Sell |
472,805
-1,595
| -0.3% | -$142K | 0.04% | 165 |
|
2019
Q4 | $54.2M | Buy |
+474,400
| New | +$54.2M | 0.04% | 170 |
|